The relationship between migraine and atopic disorders—the contribution of pulmonary function tests and immunological screening
A Özge,
C Özge, C Öztürk,
H Kaleagasi, M Özcan, DE Yalçinkaya, N Özveren, F Yalçin,
Corresponding Author
A Özge
Departments of Neurology
Dr Aynur Özge, Fatih mah. Istanbul Evleri C Blok D:5, Mezitli 33170, Mersin Turkey. Tel. + 90 32 4359 8904, fax + 90 32 4359 4336, e-mail [email protected] or [email protected]Search for more papers by this authorC Öztürk
Microbiology, Mersin University School of Medicine, Mersin, Turkey
Search for more papers by this authorA Özge,
C Özge, C Öztürk,
H Kaleagasi, M Özcan, DE Yalçinkaya, N Özveren, F Yalçin,
Corresponding Author
A Özge
Departments of Neurology
Dr Aynur Özge, Fatih mah. Istanbul Evleri C Blok D:5, Mezitli 33170, Mersin Turkey. Tel. + 90 32 4359 8904, fax + 90 32 4359 4336, e-mail [email protected] or [email protected]Search for more papers by this authorC Öztürk
Microbiology, Mersin University School of Medicine, Mersin, Turkey
Search for more papers by this authorThis study has been presented at the 8th Congress of the European Neurology Federation of Neurological Societies, Paris, 4–7 September 2004, as poster presentation (P1243–P1244).
Abstract
This cross-sectional clinical study was conducted in order to explore the relationship between atopic disorders and migraine. We evaluated 186 consecutive patients with migraine. Patients with a history of atopic disorders were compared with the others during headache-free intervals, for their headache characteristics, pulmonary test (PFT) performances and immunological screenings, through appropriate statistical methods. Of the patients with migraine, 77 (41.4%) reported at least one atopic disorder. PFT screening showed a general decreased pulmonary capacity and an important correlation between a positive history of atopic disorders and both increased eosinophil and IgE levels in headache-free periods. It should be discussed whether screening with PFT or immunological tests helps in early detection of progressive lung disease which might develop in these patients.
References
- 1 Davey G, Sedgwick P, Maier W, Visick G, Strachan DP, Anderson HR. Association between migraine and asthma: matched case–control study. Br J General Prac 2002; 52: 723–7.
- 2 Meggs WJ. Neurogenic inflammation and sensitivity to environmental chemicals. Environ Health Prospect 1993; 101: 234–8.
- 3 Grzelewska-Rzymowska I, Bogucki A, Szmidt M, Kowalski ML, Prusinski A, Rozniecki J. Migraine in aspirin sensitive asthmatics. Allergol Immunopathol (Madr) 1985; 13: 13–6.
- 4 Ferrari MD, Saxena PF. On seratonine and migraine: a clinical and pharmacological review. Cephalalgia 1993; 13: 151–6.
- 5 Case AM, Reid RL. Effects of the menstrual cycle on medical conditions. Arch Intern Med 1998; 158: 1405–12.
- 6 Egger J, Carter CM, Wilson J, Turner MW, Soothill JF. Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet 1983; 2: 865–9.
- 7 Nelson HS. The atopic diseases. Ann Allergy 1985; 55: 441–7.
- 8 Welch KM, D’Andrea G, Tepley N, Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin 1990; 8: 817–28.
- 9 Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ. New migraine preventive options: an update with pathophysiological considerations. Rev Hosp Clin Fac Med Sao Paulo 2002; 57: 293–8.
- 10 Tucker GF. Pulmonary migraine. Ann Otol Rhinol Laryngol 1977; 86: 671–6.
- 11 Hayashi T. Asthma and migraine—is asthma part of acephalgic migraine? A hypothesis. Ann Allergy 1988; 60: 374.
- 12 Gürkan F, Ece A, Haspolat K, Dikici B. Parental history of migraine and bronchial asthma in children. Allergol Immunopathol (Madr) 2000; 28: 15–7.
- 13 Chen TC, Leviton A. Asthma and eczema in children born to women with migraine. Arch Neurol 1990; 47: 1227–30.
- 14 Unger AH, Unger L. Migraine is an allergic disease. J Allergy 1952; 23: 429–40.
- 15 Mortimer MJ, Kay J, Gawkrodger DJ, Jaron A, Barker DC. The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache 1993; 33: 427–31.
- 16 Kemper RHA, Meijler WJ, Korf J, Horst GJT. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 2001; 21: 549–57.
- 17 Peckham C, Butler N. A national study of asthma in childhood. J Epidemiol Community Health 1978; 32: 79–85.
- 18 Kurtz Z, Pilling D, Blau JN, Peckham C. Migraine in children: findings from the national child developmental study. In: FC Rose, editor. Progress in migraine research. London: Pitman 1984: 9–17.
- 19 Brandes JL, Visser WH, Farmer MV, Schuhl AL, Malbecq W, Vrijens F et al. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache 2004; 44: 581–6.
- 20 Headache Classification Committe of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004; 24 (Suppl. 1): 1–150.
- 21 Quanjer PH, Tammaling GJ, Cotes JE. Lung volumes and forced respiratory flows. Report of the Working Party on Standardization of Lung Function Tests; European Community for Steel and Coal official statement of the European Respiratory Society. Eur Respir J 1993; 16: 5–40.
- 22 Ries AL. Measurement of lung volumes. Clin Chest Med 1989; 10: 177–86.
- 23 Gardner RM, Crapo RO, Nelson SB. Spirometry and flow–volume curves. Clin Chest Med 1989; 10: 145–54.
- 24 Hoyos MD. Headaches in persons attending polyclinics in Barbados. West Indian Med J 1998; 47: 59–63.
- 25 Kalyoncu AF, Çöplü L, Selçuk ZT, Emri AS, Kolacan B, Kocabas A et al. Survey of the allergic status of patients with bronchial asthma in Turkey: a multicenter study. Allergy 1995; 50: 451–5.
- 26 Vargaftig BB, Lefort J, Chignard and Benveniste J. Platelet activating factor induces a platelet dependent bronchoconstriction unrelated to the formation of prostaglandin derivates. Eur J Pharmacol 1980; 65: 185–92.
- 27 Goadsby PJ, Edvinson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of man and cat during activation of the trigeminovascular system. Ann Neurol 1988; 23: 193–6.
- 28 Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984; 16: 157–68.
- 29 Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia 1988; 8: 83–91.
- 30 Barns PS. Airway neuropeptides and asthma. TIPS 1987; 8: 24–7.
- 31 Siniatchkin M, Kirsch E, Arslan S, Stegemann S, Gerber W-D, Stephani U. Migraine and asthma in childhood: evidence for specific asymmetric parent–child interactions in migraine and asthma families. Cephalalgia 2003; 23: 790–802.
- 32 Waters WE. Allergy in migraine. In: DN Cummings, editor. Background in migraine. New York: Springer Publishing Co. Inc. 1973: 134–42.
- 33 Lord GD, Duckworth JW, Charlesworth JA. Complement activation in migraine. Lancet 1977; 1: 781–2.
- 34 Lord GD, Duckworth JW. Immunoglobulin and complement studies in migraine. Headache 1977; 17: 163–8.
- 35 Shimomura T, Araga S, Kowa H, Takahashi K. Immunoglobulin kappa/lambda ratios in migraine and tension-type headache. Jpn J Psychiatry Neurol 1992; 46: 721–6.
- 36 Jerzmanowski A, Klimek A. Immunoglobulins and complement in migraine. Cephalalgia 1983; 3: 119–23.
- 37 Rubin LS, Boyer J. A correlative study of immunoglobulin isotype expression in common migraine. Headache 1986; 26: 137–41.
- 38 Visintini D, Trabattoni G, Manzoni GC, Lechi A, Bortone L, Behan PO et al. Immunological studies in cluster headache and migraine. Headache 1986; 26: 398–402.
- 39 Leone M, Bif M, Leoni F, Bussone G. Leukocyte subsets and cortisol serum levels in patients with migraine without aura and chronic tension-type headache. Cephalalgia 1994; 14: 139–42.
- 40 Behan WM, Behan PO, Durward WF. Complement studies in migraine. Headache 1981; 21: 55–7.
- 41 Heatley RV, Denburg JA, Bayer N, Bienenstock J. Increased plasma histamine levels in migraine patients. Clin Allergy 1982; 2: 145–9.
